A diabetes pill developed by Bristol-Myers (BMY) and AstraZeneca (AZN) was effective in a Phase...

|About: Bristol-Myers Squibb Company (BMY)|By:, SA News Editor

A diabetes pill developed by Bristol-Myers (BMY) and AstraZeneca (AZN) was effective in a Phase III study, although the trial produced increased cases of bladder and breast cancers. The drug, dapagliflozin, is set to be reviewed by an FDA advisory committee in July.